Literature DB >> 9328548

Asthma mortality in Australia 1920-94: age, period, and cohort effects.

R Taylor1, E Comino, A Bauman.   

Abstract

STUDY
OBJECTIVE: To investigate asthma mortality during 1920-94 in Australia in order to assess the relative role of period and birth cohort effects.
DESIGN: Asthma mortality (both sexes) was age standardised and examined for changes over time. The data were also examined for age, period, and cohort (APC) effects using Poisson regression modelling.
SETTING: National Australian mortality data. PARTICIPANTS: Population (both sexes) aged 15-34 years, 1920-94. MAIN
RESULTS: Age adjusted period rates indicate an increase in asthma mortality during the 1950's, and increases and subsequent falls (epidemics) during the mid 1960s and late 1980s. APC modelling suggested an increasing cohort effect (adjusted for both age and period) from the birth cohort 1950-54 onwards. Period effects (adjusted for age and cohort) are characterized by an increase in the 1950s (possibly due to changes in diagnostic labelling), minimal or no increases in the mid 1960s and late 1980s (where period peaks had been noted when data were adjusted for age only), and declines in mortality risk subsequent to the periods where age-period analysis had noted increases. Thus, in Australia, some of the mid 1960s epidemic in asthma deaths, and all of the late 1980s mortality increase, seem to be attributable to cohort effects.
CONCLUSIONS: The increase in asthma mortality cohort effect is consistent with empirical evidence of recent increases in prevalence (and presumably incidence) of asthma in Australia, and suggests the need for more research into the underlying environmental aetiology of this condition.

Entities:  

Mesh:

Year:  1997        PMID: 9328548      PMCID: PMC1060510          DOI: 10.1136/jech.51.4.408

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  24 in total

1.  Trends in asthma mortality in Australia, 1911-1986.

Authors:  A Bauman; S Lee
Journal:  Med J Aust       Date:  1990-09-17       Impact factor: 7.738

2.  National survey of prevalence of asthma among children in the United States, 1976 to 1980.

Authors:  P J Gergen; D I Mullally; R Evans
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

Review 3.  Asthma: epidemics and epidemiology.

Authors:  D J Hendrick
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

4.  Models for temporal variation in cancer rates. I: Age-period and age-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

5.  Models for temporal variation in cancer rates. II: Age-period-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

6.  Asthma mortality in England and Wales: evidence for a further increase, 1974-84.

Authors:  P G Burney
Journal:  Lancet       Date:  1986-08-09       Impact factor: 79.321

Review 7.  Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.

Authors:  R Beasley; N Pearce; J Crane; C Burgess
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

8.  Asthma deaths in England and Wales 1931-85: evidence for a true increase in asthma mortality.

Authors:  P Burney
Journal:  J Epidemiol Community Health       Date:  1988-12       Impact factor: 3.710

9.  Use of antiasthmatic drugs in Australia.

Authors:  M A Jenkins; S F Hurley; G Bowes; J J McNeil
Journal:  Med J Aust       Date:  1990-09-17       Impact factor: 7.738

10.  Trends in Australian mortality of asthma, 1979-1985.

Authors:  M A Jenkins; S F Hurley; D J Jolley; R G Oliver; A J McLean; J J McNeil
Journal:  Med J Aust       Date:  1988 Dec 5-19       Impact factor: 7.738

View more
  1 in total

1.  Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort.

Authors:  R J Taylor; S L Morrell; H A Mamoon; G V Wain
Journal:  J Epidemiol Community Health       Date:  2001-11       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.